methane and cardiovascular agents

methane has been researched along with cardiovascular agents in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
GIUNTA, A; MORETTINI, A	1
Flores, AM; Hosseini-Nassab, N; Ingelsson, E; Jarr, KU; Koh, AL; Kojima, Y; Leeper, NJ; Lotfi, M; Nanda, V; Sinclair, R; Smith, BR; Tsantilas, P; Wang, Y; Weissman, IL; Wirka, R; Ye, J; Zeng, Y; Zhu, X	1

Other Studies

2 other study(ies) available for methane and cardiovascular agents

Article	Year
[Studies on cutaneous hemorrhage induced by venous stasis. VII. Effect of intra-arterial methane sulfate of dihydroergotamine]. Rivista critica di clinica medica, 1955, Volume: 55, Issue:1-6 Topics: Cardiovascular Agents; Dihydroergotamine; Ergot Alkaloids; Methane; Postthrombotic Syndrome; Purpura; Sulfates	1955
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nature nanotechnology, 2020, Volume: 15, Issue:2 Topics: Animals; Atherosclerosis; Cardiovascular Agents; CD47 Antigen; Disease Models, Animal; Female; Macrophages; Male; Mice, Transgenic; Nanomedicine; Nanotubes, Carbon; Phagocytosis; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Receptors, Immunologic; Signal Transduction	2020

Article

Year

[Studies on cutaneous hemorrhage induced by venous stasis. VII. Effect of intra-arterial methane sulfate of dihydroergotamine].

Rivista critica di clinica medica, 1955, Volume: 55, Issue:1-6

Topics: Cardiovascular Agents; Dihydroergotamine; Ergot Alkaloids; Methane; Postthrombotic Syndrome; Purpura; Sulfates

1955

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis.

Nature nanotechnology, 2020, Volume: 15, Issue:2

Topics: Animals; Atherosclerosis; Cardiovascular Agents; CD47 Antigen; Disease Models, Animal; Female; Macrophages; Male; Mice, Transgenic; Nanomedicine; Nanotubes, Carbon; Phagocytosis; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Receptors, Immunologic; Signal Transduction

2020